Building a world of personalized selling
ODAIA is a pioneer in combining process mining, customer journey mapping and AI to deliver sales and marketing insights and process automation tools to enterprise companies globally. ODAIA is headquartered in Toronto, Canada with offices in Switzerland.
Founded out of the University of Toronto, ODAIA is led by an experienced group of serial entrepreneurs, data scientists and AI engineers and is trusted by leading technology organizations.
Chief Executive Officer &
Serial entrepreneur and Silicon Valley technology executive with over 25 years of experience as a startup founder, public company executive and board member in semiconductor, IoT, SaaS and digital health.
Chief Technology Officer &
Periklis is a recognized leader in Data Analytics and Structure Discovery with over 15 years experience both in academia and industry. He has a MSc and PhD in Computer Science from the University of Toronto.
Chief Science Officer &
Gaël is a PhD candidate from the University of Lausanne, Switzerland. He is a recognized expert in applying modern machine learning and process mining techniques to improve our understanding of customer journeys.
Chief Growth Officer &
Over 8 years of customer analytics experience. Adjunct Professor, Department of Computer Science, University of Toronto.
VP, Product Engineering
Greater than 20 years in the IT industry with experience in leading technical teams to deliver complex customer solutions.
Lead Product Engineer
Experienced Software Engineering and Product professional. With a Master's degree in Engineering Product Design, Mark specializes in new product development.
Lead Machine Learning Engineer
Machine learning professional with extensive experience in the software industry for over 15 years. Academic background in Math, Physics, and Computer Science.
Commercial Lead - Life Sciences
Over 25 years of experience in Marketing Management, Global Brand Strategy and Sales Management at seven Fortune 500 companies in the biopharmaceutical industry, including Novartis, Merck, Janssen, Sanofi, Bayer, Biogen